Cardiovascular Risk Reduction and LDL-C
Evolving Perspectives in Lipid Management Learn about LDL-cholesterol, its relationship to CVD, and the role of non-statin therapies in management from clinical lipid specialists. Case study examples include clinical pearls, making the presentation easily applicable to a variety of practice settings.
Read MoreLDL Cholesterol Lowering in The Management of Atherosclerotic Cardiovascular Disease Risk
Reducing LDL-C with Non-Statin Therapies Lipid specialists Drs. Lynne Braun and Michael Miller discuss the importance of LDL cholesterol management for prevention and management of atherosclerotic cardiovascular disease (ASCVD). The role of non-statin therapies including emerging evidence with PCSK9 inhibition on major CV outcomes is presented in this dynamic presentation.
Read MoreLatest in Lipid Treatment Guidelines and Challenges
Improve Access to New LDL-C Therapies Learn current strategies for managing high-risk dyslipidemia including the use of PCSK9 Inhibitors. Case studies in familial hyperlipidemia demonstrate the application of lipid-lowering therapies in practice.
Read More